Dealings in securities by an associate of directors Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis” or “the Company”) Dealings in securities by an associate of directors In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information, relating to dealings in securities by associates of directors of the Company, is disclosed: Directors: Gary Shayne and Crispian Dillon Type of director: Both directors serve on the board of directors of the Company as non-executive directors Name of associate: Coast2Coast Capital (“C2C Capital”) in which Gary Shayne and Crispian Dillon jointly hold an indirect controlling shareholding through the ultimate holding company, Coast2Coast Communications Limited Nature of transaction: On 11 May 2018 C2C Capital agreed to purchase Ascendis shares, subject to receipt of South African Reserve Bank approval Date of transaction: 11 May 2018 Type of transaction: Off-market purchase of shares Class of shares: Ordinary shares Number of shares: 4,293,410 Price per share: R22.00 Total value of transaction: R94,455,020.00 Nature of interest: Indirect beneficial Written clearance obtained: Clearance was obtained from the Chairman Bryanston 11 May 2018 Sponsor Questco Corporate Advisory Proprietary Limited Date: 11/05/2018 09:26:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.